~0 spots leftby May 2025

Clinical Decision Support for Respiratory Infections

Recruiting in Palo Alto (17 mi)
+3 other locations
Devin Mann, MD | NYU Langone Health
Overseen byDevin Mann, MD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: NYU Langone Health
No Placebo Group

Trial Summary

What is the purpose of this trial?

This study evaluates the effects of a novel integrated clinical prediction tool on antibiotic prescription patterns of nurses for acute respiratory infections (ARIs). The intervention is an EHR-integrated risk calculator and order set to help guide appropriate, evidence-based antibiotic prescriptions for patients presenting with ARI symptoms.

Research Team

Devin Mann, MD | NYU Langone Health

Devin Mann, MD

Principal Investigator

NYU Langone Health

Eligibility Criteria

This trial is for patients aged 3-70 with sore throat and 18-70 with cough, seen at participating clinics. Nurses prescribing treatment must work at least half-time, be licensed, use the clinic's EHR system regularly, and see a sufficient number of patients to maintain skills.

Inclusion Criteria

I am between 3-70 years old with a sore throat, or 18-70 with a cough.
I visited a clinic for a cough or sore throat.
My clinic employs at least one full-time registered nurse.
See 4 more

Exclusion Criteria

I do not have chronic lung disease or a weakened immune system.
I can use English software for self-monitoring without issues.
I am unable or unwilling to give my consent for participation.
See 2 more

Treatment Details

Interventions

  • iCPR system (Clinical Decision Support)
Trial OverviewThe study tests an integrated clinical prediction tool in electronic health records (EHR) that helps nurses decide when antibiotics are needed for acute respiratory infections. It aims to ensure prescriptions are evidence-based.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: iCPR groupExperimental Treatment1 Intervention
Clinic personnel (Providers and Nurses) will receive online training that includes: 1) an overview of the project; 2) iCPR workflows including triage; 3) CPR component review and risk categories; 4) history and physical examination components of the CPRs. The online training will be followed by in-person training to reinforce the online training and teach additional skills. In-person training sessions led by study team will last approximately 60 minutes, and consist of four basic components: 1) a review of the iCPR ARI protocol and tools; 2) on-screen walk-throughs of common scenarios employing the new tools; 3) physical examination technique practice with simulated patients; A 60-minute in-person follow-up nurse training will take place 4-6 weeks after implementation of the intervention.
Group II: Control no intervention groupActive Control1 Intervention
standard care will continue as usual.

Find a Clinic Near You

Who Is Running the Clinical Trial?

NYU Langone Health

Lead Sponsor

Trials
1,431
Recruited
838,000+
Dr. Alec C. Kimmelman profile image

Dr. Alec C. Kimmelman

NYU Langone Health

Chief Executive Officer

MD and PhD from Mount Sinai School of Medicine

Dr. Nicole M. Adler profile image

Dr. Nicole M. Adler

NYU Langone Health

Chief Medical Officer since 2023

MD

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborator

Trials
3,361
Recruited
5,516,000+

Dr. Jeanne Marrazzo

National Institute of Allergy and Infectious Diseases (NIAID)

Chief Executive Officer since 2023

MD, MPH

Dr. H. Clifford Lane profile image

Dr. H. Clifford Lane

National Institute of Allergy and Infectious Diseases (NIAID)

Chief Medical Officer

MD